Fairvalue-Calculator Fairvalue-Calculator
EN DE

Outset Medical, Inc (OM) Fair Value & Analysis

Healthcare · US · Market cap $93.6M

Price$4.63
Fair Value$6.11
Upside+32.0%
Quality95/100
Evidence: Low Range $4.04 – $7.64

Fair value as of: Jun 25, 2026

Analysis

Outset Medical, Inc (OM) currently trades at $4.63, while our model-based Fair Value estimate is $6.11 — implying the stock looks roughly 32.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Outset Medical, Inc (OM) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $6.11 versus a price of $4.63 — about +32% (undervalued). Model-based estimate, not financial advice.
What is the fair value of OM?
Our 21-model fair value for Outset Medical, Inc is $6.11 (as of Jun 25, 2026), built from audited fundamentals. The current price is $4.63.
What is the quality score of OM?
Outset Medical, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.